ArticleFrontiers in oncology2026
Primary malignant peripheral nerve sheath tumor of the liver: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Malignant peripheral nerve sheath tumor (MPNST) is a malignant neoplasm originating from Schwann cells or other nerve sheath components. It most commonly arises in the extremities and trunk. Primary hepatic MPNST is extremely rare, and most cases are associated with neurofibromatosis type 1 (NF-1). Case presentation: This study reports a rare case of hepatic MPNST without NF-1 in a 56-year-old female. The patient presented with upper abdominal pain and distention. Serum tumor markers were all within normal ranges. Radiological examination identified a hypovascular hepatic lesion, which was pathologically confirmed as MPNST. Radical tumor resection was performed. The patient has been followed up for approximately 2 years, with no signs of recurrence or metastasis. Conclusion: The clinical manifestation of hepatic MPNST is nonspecific with normal tumor markers. Radiologically, it mainly manifests as a hypovascular tumor, which requires differentiation from hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and hepatic angiosarcoma. With a literature review, our article provides a comprehensive summary of its CEUS and CECT manifestations, thereby supplementing the limited available data on this rare entity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.